Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?

Recurrence of coronavirus disease 19 (COVID-19) symptoms and SARS-CoV-2 viral load relapse have been reported in people treated with nirmatrelvir/ritonavir (NM/r). However, little is understood about the etiology of this phenomenon. Our aim was to investigate the relation between the host’s immune r...

Descripción completa

Detalles Bibliográficos
Autores principales: Panza, Francesca, Fiorino, Fabio, Pastore, Gabiria, Fiaschi, Lia, Tumbarello, Mario, Medaglini, Donata, Ciabattini, Annalisa, Montagnani, Francesca, Fabbiani, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609571/
https://www.ncbi.nlm.nih.gov/pubmed/37894265
http://dx.doi.org/10.3390/microorganisms11102607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609571/
https://www.ncbi.nlm.nih.gov/pubmed/37894265
http://dx.doi.org/10.3390/microorganisms11102607

Ejemplares similares